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Abstract Chalcone was prepared by the condensation of arylmethyl ketone 
and arylaldehyde in the presence of alcoholic alkali. Present study describes the 
synthesis of a series of (2z)-3-[2-(4-chlorophenyl)-8-methyl imidazo[1,2-a] 
pyridine-3-yl]-1-substituted arylprop-2-en-1-one compounds (h) 1-9. The 
compounds were characterized by modern analytical techniques such as CHN 
analyses, IR, 1H NMR spectra and further supported by mass spectroscopy. 
All the title compounds were screened for their in vitro antibacterial and 
antifungal activity against B.coccus, S.aureus, Pseudomona, E.coli, A.niger, 
Ampicillin, Amoxicillin, Ciprofloxacin, Norfloxacin, Greseofulvin. Their 
minimum inhibitory concentrations (MIC) were determined. The results of 
antibacterial activity showed that compounds h 4, h 9 and antifungal activity 
compounds h 1, h 9 using standard drug.
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INTRODUCTION
The chemistry of chalcones have generated intensive scientific studies throughout the world, specially interesting are their biological and industrial applications. Chalcones are coloured compounds because 
of presence of the chromophore and auxochromes. They are known as 
benzalacetophenones or benzylidene acetophenones. Kostanecki and Tambor 
(1899) gave the name “Chalcone”. Chalcones are characterized by their 
possession of a structure in which two aromatic ring are linked by an aliphatic 
three carbon chain. The alternative names given to chalcones are phenyl styryl 






A considerable variety of methods are available for the synthesis 
of chalcones. The most convenient method is the one that involves the 
Claisenschimdt condensation of equimolar quantities of an arylmethyl ketone 
with arylaldehyde in the presence of alcoholic alkali. (Kazauki et al., 1976). 
Several condensing agents used are alkali of different strength (Rupe and 
Wasserzug, 1901; Szell,  1959) hydrogen chloride (Lyle and Paradis, 1955; 
Hemes, 1969), phosphorous oxychloride (Rawal and Shah, 1962), piperidine 
(Cheng et al., 1963), anhydrous aluminium chloride (Kurodo and Matsukuma, 
1932), boron trifluoride (Breslow and Houser, 1940), aq.solution of borax 
(Jadav and Kulkarni, 1944), amino acids (Reichel, 1944), and perchloric acid 
(Vlasov, 1972) etc. 
Chalcones are potential biocides, some naturally occurring antibiotics 
and amino chalcones probably own their biological activity to the presence 
of α, β - unsaturated carbonyl group. Chalcone derivatives are associated 
with diverse biological activity. Antiallergic (Ogansyan et al., 1991), 
Carboxygenase inhibitir (Satoshi et al., 1993), Antitumor (Satomi. 1993, 
1994; Auto et al., 1994, 1995), Antimalarial (Li et al., 1995, 1996), Anticancer 
(Zongru and Rui, 1996), Insecticidal (Nissan Chemical Industries, 1983; 
Seele R. et al., 1989, 1990), Antiulcer (Tashio Pharmaceutical Co. Ltd., 
1984), Antiinflammatory (Serre et al., 1979; Vanstone et al., 1986, 1987), 
9. Bactericidal (Bowden et al., 1990, 1991; Inamori et al., 1991, 1991), 
10. fungicidal (Gaurav and Ingle, 1986, 1987;  Pedersen and Fitz Gerald, 
1985), 11. antiviral (Binder et al., 1985), 12. Anthelmintics (Bell, 1984, 
1990).
Recently, Ni Liming et al., (2002, 2003) have synthesized chalcones 
and screened for their antiinflammatory and cardiovascular activity. Kumar 
Srinivas et al. (2003) have synthesized chalcones as an antitumor agent. Ko 
horng-Huey et al. (2003) have prepared chalcones as an antiinflammatory 
agent. Nakahara Kazuhiko et al. (2003, 2003) have synthesized chalcones 
as carcinogen inhibitors. Antitubercular agents of chalcone derivatives have 
been prepared by Lin Yuh-Meei et al. (2002, 2003) Ezico et al. (1999) have 
demonstrated that chalcone possess a valuable anti-proliferation activity 
both on sensitive cancereous cell and on cell which are resistant to common 
chemotherapeutic drugs. Some of the chalcones have been patented for their 
use for treatment of glueoma (Elichi and Koji, 2000) and showed anti-fungal 
(Kalashnikov and Kalashnikov, 1994; Satoshi et al., 1993, 1994) aldose 
reductase inhibitors (Walavalkar and Pednekar, 1999), anticancer (Toru et al., 













Melting points were determined in open capillary tubes and are uncorrected. 
Formation of the compounds was routinely checked by TLC on silica gel-G 
plates of 0.5 mm thickness and spots were located by iodine. IR spectra were 
recorded on Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass 
spectra were recorded on Waters micromass Q –Tof model instrument. 1H 
NMR was determined in CDCl3 solution on a Brucker 400 MHz spectrometer. 
Elemental analysis of all the synthesized compounds was carried out on 
Elemental Vario EL III carlo Erba 1108 model and the results are in agreements 
with the structures assigned.
Reaction Scheme
Synthesis of substituted Chalcone derivatives
The product substituted Chalcone derivatives (h) 1-9 has been synthesized 
by the reaction of aldehyde with different substituted ketone in presence of 
alcoholic alkali.
General method for the synthesis of (2z)-3-[2-(4-chlorophenyl)-8-
methylimidazo[1,2-a]pyridine-3-yl]-1-aryl prop-2-en-1-one (h 1-9).
A mixture 2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-





(1.50gm,0.01m) was refluxed in methanol for 6 hrs. NaOH is used as catalyst. 




Yield 59%; M.P. 215 °C; IR (KBr, cm-1): 3066 (aromatic C-H str.), 2918 ( 
alkane asym. C-H str.), 2852 (-CH3 sym. C-H str.), 1658 ( C=O str.), 1645 
(CH=CH- str.), 1587 (C=N- str.), 794 (C-Cl str.); 1H NMR (CDCl3): δ (ppm) 
2.71 (s, 3H, Ar-CH3), 7.02-7.95 (d, 8H, Ar-H), 7.45-8.15 (d, 2H, -CH=CH-), 
8.48 (d, 1H, -CH=N); MS: m/z 373(M+), 310, 268, 242, 146, 132; Element 
Analysis for C23H17N2ClO; Calculated: C, 74.09; H, 4.60; N, 7.51%. Found : 
C, 74.00; H, 4.56; N, 7.36%.
(2z)-3-[2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-yl]-1-(4-
methylphenyl)prop-2-en-1-one(h 2).
Yield 56%; M.P. 262 °C; IR (KBr, cm-1): 3065 (aromatic C-H str.), 2918 ( 
alkane asym. C-H str.), 2855 (-CH3 sym. C-H str.), 1655 ( C=O str.), 1642 
(CH=CH- str.), 1584 (C=N- str.), 796 (C-Cl str.); 1H NMR (CDCl3): δ (ppm) 
2.73 (s, 6H, Ar-CH3), 6.97-8.00 (d, 8H, Ar-H), 7.55-8.20 (d, 2H, -CH=CH-), 
8.40 (d, 1H, -CH=N); MS: m/z 387(M+), 310, 268, 242, 146, 132; Element 
Analysis for C24H19ClN2O; Calculated: C, 74.51; H, 4.95; N, 7.24%. Found : 
C, 74.36; H, 4.72; N, 7.12%.
(2z)-3-[2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-yl]-1-(4-
methoxylphenyl)prop-2-en-1-one(h 3).
Yield 75%; M.P. 189 °C; IR (KBr, cm-1): 3066 (aromatic C-H str.), 2918 ( 
alkane asym. C-H str.), 2852 (-CH3 sym. C-H str.), 1658 ( C=O str.), 1640 
(CH=CH- str.), 1587 (C=N- str.), 795 (C-Cl str.); 1H NMR (CDCl3): δ (ppm) 
2.70 (s, 3H, Ar-CH3), 3.90 (s, 3H, Ar-OCH3), 6.97-7.95 (d, 8H, Ar-H), 7.55-
8.15 (d, 2H, -CH=CH-), 8.43 (d, 1H, -CH=N); MS: m/z 403(M+), 310, 268, 
242, 146, 132; Element Analysis for C24H19ClN2O2; Calculated: C, 71.55; H, 
4.75; N, 6.95%. Found : C, 71.63; H, 4.72; N, 6.78%.
(2z)-3-[2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-yl]-1-(4-
chlorophenyl)prop-2-en-1-one(h 4).
Yield 72%; M.P. 185 °C; IR (KBr, cm-1): 3060 (aromatic C-H str.), 2922 ( 











(CH=CH- str.), 1590 (C=N- str.), 792 (C-Cl str.); 1H NMR (CDCl3): δ (ppm) 
2.75 (s, 3H, Ar-CH3), 7.00-7.95 (d, 8H, Ar-H), 7.50-8.15 (d, 2H, -CH=CH-), 
8.45 (d, 1H, -CH=N); MS: m/z 408(M+), 310, 268, 242, 146, 132; Element 
Analysis for C23H16Cl2N2O; Calculated: C, 67.83; H, 3.96; N, 6.88%. Found : 
C, 67.88; H, 3.92; N, 6.76%.
(2z)-3-[2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-yl]-1-(4-
fluorophenyl)prop-2-en-1-one(h 5).
Yield 65%; M.P. 140 °C; IR (KBr, cm-1): 3055 (aromatic C-H str.), 2920 ( 
alkane asym. C-H str.), 2855 (-CH3 sym. C-H str.), 1658 ( C=O str.), 1645 
(CH=CH- str.), 1585 (C=N- str.), 1210 (C-F str.), 800 (C-Cl str.); 1H NMR 
(CDCl3): δ (ppm) 2.72 (s, 3H, Ar-CH3), 6.95-7.90 (d, 8H, Ar-H), 7.60-8.18 (d, 
2H, -CH=CH-), 8.49 (d, 1H, -CH=N); MS: m/z 391(M+), 310, 268, 242, 146, 
132; Element Analysis for C23H16ClFN2O; Calculated: C, 70.68; H, 4.13; N, 
7.17%. Found : C, 70.62; H, 4.12; N, 6.98%.
(2z)-3-[2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-yl]-1-(4-
bromophenyl)prop-2-en-1-one(h 6).
Yield 57%; M.P. 243 °C; IR (KBr, cm-1): 3058 (aromatic C-H str.), 2918 ( 
alkane asym. C-H str.), 2856 (-CH3 sym. C-H str.), 1655 ( C=O str.), 1651 
(CH=CH- str.), 1589 (C=N- str.), 552 (C-Br str.), 796 (C-Cl str.); 1H NMR 
(CDCl3): δ (ppm) 2.70 (s, 3H, Ar-CH3), 7.00-7.95 (d, 8H, Ar-H), 7.55-8.10 (d, 
2H, -CH=CH-), 8.44 (d, 1H, -CH=N); MS: m/z 452(M+), 310, 268, 242, 146, 
132; Element Analysis for C23H16ClBrN2O; Calculated: C, 61.15; H, 3.57; N, 
6.20%. Found : C, 61.10; H, 3.53; N, 6.15%.
(2z)-3-[2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-yl]-1-(4-
aminophenyl)prop-2-en-1-one(h 7).
Yield 55%; M.P. 165 °C; IR (KBr, cm-1): 3345 (N-H str.), 3060 (aromatic C-H 
str.), 2915 ( alkane asym. C-H str.), 2852 (-CH3 sym. C-H str.), 1658 ( C=O 
str.), 1649 (CH=CH- str.), 1590 (C=N- str.), 800 (C-Cl str.); 1H NMR (CDCl3): 
δ (ppm) 2.78 (s, 3H, Ar-CH3), 6.90-7.00 (d, 8H, Ar-H), 7.62-8.22 (d, 2H, 
-CH=CH-), 8.49 (d, 1H, -CH=N); MS: m/z 388(M+), 310, 268, 242, 146, 132; 
Element Analysis for C23H18ClN3O; Calculated: C, 71.22; H, 4.68; N, 10.83%. 







Yield 70%; M.P. 161 °C; IR (KBr, cm-1): 3066 (aromatic C-H str.), 2920 ( 
alkane asym. C-H str.), 2855 (-CH3 sym. C-H str.), 1651 ( C=O str.), 1644 
(CH=CH- str.), 1595 (C=N- str.), 1510 (N-O str.), 796 (C-Cl str.); 1H NMR 
(CDCl3): δ(ppm) 2.75 (s, 3H, Ar-CH3), 6.97-7.15 (d, 8H, Ar-H), 7.61-8.15 (d, 
2H, -CH=CH-), 8.45 (d, 1H, -CH=N); MS: m/z 418(M+), 310, 268, 242, 146, 
132; Element Analysis for C23H16ClN3O3; Calculated: C, 66.11; H, 3.86; N, 
10.06%. Found : C, 66.08; H, 3.83; N, 9.88%.
(2z)-3-[2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-yl]-1-(4-
hydroxyphenyl)prop-2-en-1-one(h 9).
Yield 54%; M.P. 149 °C; IR (KBr, cm-1): 3450 (O-H str.), 3062 (aromatic C-H 
str.), 2915 ( alkane asym. C-H str.), 2859 (-CH3 sym. C-H str.), 1655 ( C=O 
str.), 1640 (CH=CH- str.), 1592 (C=N- str.), 798 (C-Cl str.); 1H NMR (CDCl3): 
δ(ppm) 2.80 (s, 3H, Ar-CH3), 9.45 (Ar-OH), 6.90-7.30 (d, 8H, Ar-H), 7.55-
8.15 (d, 2H, -CH=CH-), 8.50 (d, 1H, -CH=N); MS: m/z 389(M+), 310, 268, 
242, 146, 132; Element Analysis for C23H16ClN3O3; Calculated: C, 71.04; H, 
4.41; N, 7.20%. Found : C, 71.00; H, 4.35; N, 7.04%.















h 1 C6H5- C23H17ClN2O 372.5 215.0 0.54 59.0 7.51 7.36
h 2 4-CH3-C6H4- C24H19ClN2O 386.5 262.0 0.58 56.0 7.24 7.12
h 3 4-OCH3-C6H4- C24H19ClN2O2 402.5 189.0 0.60 75.0 6.95 6.78
h 4 4-Cl-C6H4- C23H16Cl2N2O 407.0 185.0 0.59 72.0 6.88 6.76
h 5 4-F-C6H4- C23H16ClFN2O 390.5 140.0 0.44 65.0 7.17 6.98
h 6 4-Br-C6H4- C23H16ClBrN2O 451.5 243.0 0.62 57.0 6.20 6.15
h 7 4-NH2-C6H4- C23H18ClN3O 387.5 165.0 0.56 55.0 10.83 10.79
h 8 4-NO2-C6H4- C23H16ClN3O3 417.5 161.0 0.56 70.0 10.06 9.88












All the compounds have been evaluated for antimicrobial activity using Cup-
plate agar diffusion method at a concentration of 40μg using DMF as a solvent 
against different strains of bacteria and fungi. The antimicrobial activity was 
compare with standard drug viz ciprofloxacin, Amoxicillin, Benzyl-penicillin 
and antifungal activity was compared with viz greseofulvin. The zone of 
inhibition were measured in mm.
Antibacterial Activity
The purified products were screened for their antimicrobial activity. The 
nutrient agar broth prepared by the usual method, was inoculated aseptically 
with 0.5 ml of 24 hrs. old subcultures of B.cocus, S.aureus, Pseudomonas 
and E.coli in separate conical flask at 40-50°C and mixed well by gentle 
sacking. About 25ml content of the flask were poured and evenly spreaded in 
a petridish (13mm in diameter) and allowed to set for 2 hrs. The cups (10mm 
in diameter) were formed by the help of borar in agar medium and filled with 
0.04ml (40mg) solution of sample in DMF.
The plates were incubated at 37°C for 24.0 hrs. and the control was also 
maintained with 0.04 mole of DMF in a similar manner and the zones of 
inhibition of bacterial growth were measured in millimeter.
Antifungal Activity
A.Niger was employed for testing antifungal activity using cup-plate method. 
The culture was maintained on Subouraud’s agar slants. Steriled Subouraud’s 
agar medium was inoculated with 72 hrs. Old 0.5ml suspension of fungal 
spores in a separate flask. 
About 25ml of inoculated medium was evenly spreaded in a petridish and 
allowed to set for two hrs. The cups (10 mm in diameters) were punched in 
petridish and loaded with (0.04g) of solution of sample in DMF. The plates 
were incubated at 30°C for 48 hrs. After the completion of incubation period, 
the zone of inhibition of growth in the form of diameter in mm was measured. 
Along the test solution in each petridish one cup was filled with solvent which 
act as control. The zones of inhibition are recorded in Table 2.
RESULTS AND DISCUSSION
Synthesized all compounds of (2z)-3-[2-(4-chlorophenyl)-8-methyl imidazo[1,2-a]
pyridine-3-yl]-1-(substituted aryl)prop-2-en-1-one starting from chlorobenzene were 






IR spectra of each compound showed a band for C=O stretching vibrations 
near 1650 cm-1, aromatic C-H stretching 3060 cm-1. while primary amine 3350 
cm-1, O-H stretching at 3450 cm-1. In case of 1H NMR shown the chemical shift 
value of Ar-CH3 at near 2.70 δ ppm, CH=CH- at near 7.50-8.15 δ ppm . All 
the title compounds showed [M+] of 100% intensity as the molecular ion peak. 
Compound containing chlorine showed isotopic peak at [M+2] of about 33% 
intensity of that of parent ion peak where as bromo derivative showed isotopic 
peak at [M+2] of about equal intensity. The results of elemental analyses were 
found in good agreement with calculated values.




Zone of Inhibition in m.m.
Antibacterial Antifungal
B.coccus S.aureus Pseudomona E.coli A.niger
h 1 C6H5- 17 16 13 12 19
h 2 4-CH3-C6H4- 15 13 15 14 13
h 3 4-OCH3-C6H4- 16 15 14 15 12
h 4 4-Cl-C6H4- 18 18 15 16 14
h 5 4-F-C6H4- 16 14 15 15 16
h 6 4-Br-C6H4- 14 12 13 12 13
h 7 4-NH2-C6H4- 15 14 14 13 15
h 8 4-NO2-C6H4- 13 12 13 14 15
h 9 4-OH-C6H4- 19 16 18 18 18
Stdn Ampicillin 20 19 21 22 -
“ Amoxicillin 22 20 20 21 -
“ Ciprofloxacin 24 23 22 20 -
“ Norfloxacin 23 21 21 22 -












Present study describes the synthesis of a series of (2z)-3-[2-(4-chlorophenyl)-
8-methyl imidazo[1,2-a]pyridine-3-yl]-1-substituted arylprop-2- en-1-one. 
The compounds were characterized by modern analytical techniques such as 
C, H, N analyses, IR, Mass and proton NMR spectra. All the title compounds 
were screened for their in vitro antibacterial and antifungal activity against 
B.coccus, S.aureus, Pseudomona, E.coli, A.niger, Ampicillin, Amoxicillin, 
Ciprofloxacin, Norfloxacin, Greseofulvin. Their minimum inhibitory 
concentrations (MIC) were determined. The results of antibacterial activity 
showed that compounds h 4, h 9 and antifungal activity compounds h 1, h 9 
using standard drug.
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